Elizabeth Norgett

Elizabeth Norgett has extensive work experience in the field of research, with a focus on genetic mechanisms and physiological effects of renal tubular disorders. Elizabeth started their career as a research technician at Queen Mary University of London in 1999 and later became a PhD student. In 2004, they joined the University of Cambridge as a research associate, where they worked on projects related to renal tubular disorders for over a decade. During their time at Cambridge, they also co-founded Kalium Health Ltd in 2018 and served as its co-founder and director until 2020. Elizabeth Norgett currently holds the position of Chief Scientific Officer at Kalium Health Ltd.

Elizabeth Norgett completed their Bachelor of Science (Hons) degree in Genetics from the University of Liverpool in 1999. Elizabeth then pursued a PhD in Genetics from Queen Mary University of London from 2001 to 2004. In 2018, Elizabeth enrolled in two programs at the Cambridge Judge Business School, namely Accelerate Cambridge and Ignite 2018. However, the field of study for their business school programs is not specified in the information provided.